Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Elon Musk, CEO of Tesla and SpaceX, shared his dramatic weight loss attributed to the GLP-1 inhibitor Mounjaro, used ...

GLP-1 receptor agonists (GLP-1RAs) on multiple fronts. They continued to expand into new indications, and provide their developers with both rich remuneration and scientific acclamation. There are now ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company’s stock ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Losing weight on a GLP-1 can lead to muscle loss, research shows. Here, obseity experts share how to preserve your lean ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

The world’s richest man has clashed with incoming Health and Human Services chief Robert F. Kennedy Jr. over the role weight-loss medications should play in making Americans healthier and thinner.

Two SciFri producers discuss the year’s most intriguing stories, from new weight-loss drugs to PFAS chemicals to the ...